Similar to CSF findings, plasma GFAP is elevated across multiple neurodegenerative diseases, including frontotemporal dementia, Parkinson’s disease dementia, dementia with Lewy bodies, and AD. This evidence concerns the gene GFAP and Alzheimer disease.